kapi

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya

As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview to drive a common agenda to flatten the curve of transmission, build concerted efforts to ensure uninterrupted supply of medicines, diagnostics and healthcare technologies. Additionally, our member companies have been […]

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya Read More »

KAPI confirms commitment to affordably deliver Non-Communicable Diseases medicines

The Kenya Association of Pharmaceutical Industry (KAPI) has expressed its commitment to continue facilitating a progressive reduction in the cost of Non communicable diseases (NCDs) medicines locally. In a swift response to a public call by President Uhuru Kenyatta to international pharmaceutical firms, to reduce the cost of NCD medicines, KAPI, has confirmed ongoing efforts

KAPI confirms commitment to affordably deliver Non-Communicable Diseases medicines Read More »

KENYA FEATURES PROMINENTLY IN GLOBAL PHARMACEUTICAL INDUSTRY REPORT

…As the global pharmaceutical industry advocates for even greater collaboration as critical to future global health progress The International Federation of Pharmaceutical Manufacturers & Associations IFPMA has launched a report detailing milestones achieved in the health sector worldwide over the last 50 years. The report launched today features Kenya as a key player in the

KENYA FEATURES PROMINENTLY IN GLOBAL PHARMACEUTICAL INDUSTRY REPORT Read More »